Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin M Posadas

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Nature Reviews. Nephrology|July 11, 2017
Targeted therapies for renal cell carcinomaEdwin M Posadas, Suwicha Limvorasak, Robert A Figlin
Current Opinion in Oncology|August 18, 2004
Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literatureEdwin M Posadas, Ben Davidson, Elise C Kohn
Oncology (Williston Park, N.Y.)|September 17, 2016
Third-Line Treatment Options for Kidney CancerEdwin M Posadas, Suwicha Limvorasak, Robert A Figlin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2019
Brain Metastases in Renal Cell Carcinoma: Immunotherapy Responsiveness Is Multifactorial and HeterogeneousJarred P Reed, Edwin M Posadas, Robert A Figlin
Translational Andrology and Urology|July 10, 2012
Future perspectives of prostate cancer therapyMurali Gururajan, Edwin M Posadas, Leland W K Chung
Drugs|December 21, 2016
Recent Advances in the Medical Treatment of Recurrent or Metastatic Renal Cell CancerRekha A Kumbla, Robert A Figlin, Edwin M Posadas
Oncology and Therapy|April 2, 2025
Shared Decision-Making for Advanced Renal Cell Carcinoma: Focus on Adverse Event Management of Axitinib Plus IO: A VodcastEdwin M Posadas, Nancy Moldawer, Greg Biddulph, et al.
Nature Reviews. Urology|June 17, 2024
Progression-free survival end points in prostate cancer: are we truly making progressRavi A Madan, Edwin M Posadas, Richard J Lee
Expert Review of Anticancer Therapy|January 24, 2019
Developments in the use of tyrosine kinase inhibitors in the treatment of renal cell carcinomaJarred P Reed, Edwin M Posadas, Robert A Figlin
Expert Opinion on Pharmacotherapy|August 30, 2013
Targeting angiogenesis in renal cell carcinomaEdwin M Posadas, Suwicha Limvorasak, Shaleekha Sharma, et al.
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Nature Reviews. Nephrology|July 11, 2017
Targeted therapies for renal cell carcinomaEdwin M Posadas, Suwicha Limvorasak, Robert A Figlin
Current Opinion in Oncology|August 18, 2004
Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literatureEdwin M Posadas, Ben Davidson, Elise C Kohn
Oncology (Williston Park, N.Y.)|September 17, 2016
Third-Line Treatment Options for Kidney CancerEdwin M Posadas, Suwicha Limvorasak, Robert A Figlin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2019
Brain Metastases in Renal Cell Carcinoma: Immunotherapy Responsiveness Is Multifactorial and HeterogeneousJarred P Reed, Edwin M Posadas, Robert A Figlin
Translational Andrology and Urology|July 10, 2012
Future perspectives of prostate cancer therapyMurali Gururajan, Edwin M Posadas, Leland W K Chung
Drugs|December 21, 2016
Recent Advances in the Medical Treatment of Recurrent or Metastatic Renal Cell CancerRekha A Kumbla, Robert A Figlin, Edwin M Posadas
Oncology and Therapy|April 2, 2025
Shared Decision-Making for Advanced Renal Cell Carcinoma: Focus on Adverse Event Management of Axitinib Plus IO: A VodcastEdwin M Posadas, Nancy Moldawer, Greg Biddulph, et al.
Nature Reviews. Urology|June 17, 2024
Progression-free survival end points in prostate cancer: are we truly making progressRavi A Madan, Edwin M Posadas, Richard J Lee
Expert Review of Anticancer Therapy|January 24, 2019
Developments in the use of tyrosine kinase inhibitors in the treatment of renal cell carcinomaJarred P Reed, Edwin M Posadas, Robert A Figlin
Expert Opinion on Pharmacotherapy|August 30, 2013
Targeting angiogenesis in renal cell carcinomaEdwin M Posadas, Suwicha Limvorasak, Shaleekha Sharma, et al.
Pageof 12